文献速递心力衰竭与心肌病瓣膜病与结构性心脏病

射血分数降低心衰合并主动脉瓣狭窄的机械干预

Mechanical Intervention for Aortic Valve Stenosis in Patients With Heart Failure and Reduced Ejection Fraction.
PubMed 文献 · J Am Coll Cardiol · 2017-01-01

该综述聚焦合并射血分数降低心衰(HFrEF)的主动脉瓣狭窄患者,梳理其流行病学与病理生理,并汇总现有注册研究与临床试验数据。文中指出经导管主动脉瓣置换等非外科机械干预可能改变此类高危患者的风险-获益比,并讨论在研试验与潜在临床流程。

要点

  • HFrEF合并主动脉瓣狭窄属高危人群,外科换瓣风险较高。
  • 经导管主动脉瓣置换等非外科干预可能改善该人群风险-获益比。
  • 现有证据多来自注册研究与试验,仍需在研试验进一步验证。

核心结论

  • 合并射血分数降低心衰的主动脉瓣狭窄患者为高危人群,非外科机械干预可能改变其风险-获益比。

研究设计与样本

  • 综述,描述主动脉瓣狭窄合并射血分数降低心衰的流行病学与病理生理,并汇总相关注册与临床试验数据。

主要发现

  • 既往瓣膜病机械干预的风险与获益主要在射血分数正常人群中描述,该高危人群数据有限。

临床怎么用

  • 对合并射血分数降低心衰的主动脉瓣狭窄患者,可参考非外科机械干预证据评估治疗策略。

局限性

  • 综述性质,证据来自注册与临床试验汇总,尚待正在进行的试验提供新数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The risk and benefit of mechanical interventions in valvular heart disease have been primarily described among patients with normal ejection fraction. The advent of nonsurgical mechanical interventions for aortic stenosis (transcatheter aortic valve replacement) may alter the risk-benefit ratio for patients who would otherwise be at increased risk for valve surgery. This review describes the epidemiology and pathophysiology of aortic stenosis with heart failure and reduced ejection fraction and summarizes the current registry and clinical trial data applicable to this frequently encountered high-risk group. It concludes with discussion of ongoing trials, new approaches, emerging indications, and a potential clinical algorithm incorporating optimal mechanical intervention for patients with aortic stenosis and concomitant reduced ejection fraction.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Steiner J, Rodés-Cabau J, Holmes DR, et al. Mechanical Intervention for Aortic Valve Stenosis in Patients With Heart Failure and Reduced Ejection Fraction. J Am Coll Cardiol. 2017. PMID: 29241492. doi:10.1016/j.jacc.2017.10.040

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。